Cellectis SA (CLLS)
1.77
-0.03
(-1.67%)
USD |
NASDAQ |
Nov 04, 16:00
1.77
0.00 (0.00%)
After-Hours: 20:00
Cellectis 1 Year Total Returns (Daily): -31.82% for Nov. 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 01, 2024 | -31.82% |
October 31, 2024 | 83.51% |
October 30, 2024 | 79.28% |
October 29, 2024 | 81.51% |
October 28, 2024 | 91.43% |
October 25, 2024 | 86.00% |
October 24, 2024 | 80.95% |
October 23, 2024 | 64.17% |
October 22, 2024 | 48.76% |
October 21, 2024 | 51.65% |
October 18, 2024 | 42.86% |
October 17, 2024 | 41.48% |
October 16, 2024 | 38.69% |
October 15, 2024 | 36.96% |
October 14, 2024 | 41.30% |
October 11, 2024 | 43.06% |
October 10, 2024 | 37.93% |
October 09, 2024 | 36.36% |
October 08, 2024 | 35.17% |
October 07, 2024 | 35.86% |
October 04, 2024 | 33.38% |
October 03, 2024 | 28.57% |
October 02, 2024 | 30.67% |
October 01, 2024 | 27.85% |
September 30, 2024 | 34.18% |
Date | Value |
---|---|
September 27, 2024 | 36.50% |
September 26, 2024 | 35.19% |
September 25, 2024 | 35.00% |
September 24, 2024 | 28.49% |
September 23, 2024 | 27.91% |
September 20, 2024 | 38.47% |
September 19, 2024 | 41.46% |
September 18, 2024 | 39.88% |
September 17, 2024 | 36.05% |
September 16, 2024 | 33.72% |
September 13, 2024 | 27.84% |
September 12, 2024 | 36.36% |
September 11, 2024 | 32.59% |
September 10, 2024 | 26.86% |
September 09, 2024 | 28.86% |
September 06, 2024 | 24.44% |
September 05, 2024 | 24.04% |
September 04, 2024 | 14.43% |
September 03, 2024 | 12.44% |
August 30, 2024 | 13.74% |
August 29, 2024 | 25.33% |
August 28, 2024 | 24.74% |
August 27, 2024 | 25.26% |
August 26, 2024 | 26.32% |
August 23, 2024 | 21.68% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-84.75%
Minimum
Jun 14 2022
172.9%
Maximum
Mar 22 2021
-13.65%
Average
-19.89%
Median
May 11 2020
1 Year Total Returns (Daily) Benchmarks
Genfit SA | 94.79% |
DBV Technologies SA | -62.69% |
Edap TMS SA | -57.69% |
Adaptimmune Therapeutics PLC | 48.11% |
Akari Therapeutics PLC | -22.56% |